Clinical Trial Update: Upneeq vs. Lumify Ptosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Upneeq with Lumify for acquired ptosis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Ptosis

Drugs mentioned

• Lumify (phenylephrine)
• Upneeq (oxymetazoline)

Snippet

Sponsor: Duke University | Conditions: Acquired Ptosis | Phase 4 | Status: NOT_YET_RECRUITING